Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

STERIS plc (NYSE:STE)

70.59
Delayed Data
As of May 02
 -0.08 / -0.11%
Today’s Change
60.75
Today|||52-Week Range
78.77
-6.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$6.1B

Company Description

STERIS Plc manufactures surgical and other medical supplies. It focuses primarily on healthcare, medical devices, pharmaceuticals, and research. The company operates through the following segments: Healthcare Products, Healthcare Specialty Services, Life Sciences and Applied Sterilization Technologies. The Healthcare Products segment offers infection prevention and procedural solutions for healthcare providers worldwide, including capital equipment and related maintenance and installation services, as well as consumables. The Healthcare Specialty Services segment provides a range of specialty services for healthcare providers including hospital sterilization services, instrument and scope repairs, and linen management. The Life Sciences segment offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities. The Applied Sterilization Technologies segment offers a contract sterilization and laboratory services for medical device and pharmaceutical Customers and others. STERIS was founded on October 9, 2014 and is headquartered in Leicester, United Kingdom.

Contact Information

STERIS Plc
Chancery House
Leicester Leicestershire LE5 1QZ
P:444403542600
Investor Relations:
444403927245

Employees

Shareholders

Mutual fund holders58.99%
Other institutional40.71%
Individual stakeholders1.69%

Top Executives

Walter M. RosebroughPresident, Chief Executive Officer & Director
Michael J. TokichChief Financial Officer, Treasurer & Senior VP
John Adam ZangerleSecretary, Vice President & General Counsel
Julie WinterDirector-Investor Relations